WallStreetZenWallStreetZen

NASDAQ: JANX
Janux Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for JANX

Based on 6 analysts offering 12 month price targets for Janux Therapeutics Inc

Min Forecast
$41.00+39.93%
Avg Forecast
$97.67+233.33%
Max Forecast
$200.00+582.59%

Should I buy or sell JANX stock?

Based on 6 analysts offering ratings for Janux Therapeutics Inc.

Strong Buy
Strong Buy
3 analysts 50%
Buy
2 analysts 33.33%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although JANX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates JANX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their JANX stock forecasts and price targets.

JANX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-03
lockedlocked$00.00+00.00%2025-02-28
lockedlocked$00.00+00.00%2024-12-11
lockedlocked$00.00+00.00%2024-12-03
lockedlocked$00.00+00.00%2024-12-03
UBS
Bottom 5%
5
Strong BuyInitiates Coverage On$69.00+135.49%2024-10-24

1 of 1

Forecast return on equity

Is JANX forecast to generate an efficient return?

Company
-13.49%
Industry
153.19%
Market
81.87%
JANX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is JANX forecast to generate an efficient return on assets?

Company
-13%
Industry
36.07%
JANX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

JANX earnings per share forecast

What is JANX's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$2.22
Avg 2 year Forecast
-$2.53
Avg 3 year Forecast
-$3.41

JANX revenue forecast

What is JANX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$33.6M+217.72%
Avg 2 year Forecast
$142.8M+1,248.46%
Avg 3 year Forecast
$439.7M+4,052.4%
JANX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

JANX revenue growth forecast

How is JANX forecast to perform vs Biotechnology companies and vs the US market?

Company
240.01%
Industry
65.48%
Market
10.37%
JANX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
JANX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

JANX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
JANX$29.30$97.67+233.33%Strong Buy
BLTE$54.69$96.67+76.75%Strong Buy
KYMR$27.16$58.00+113.55%Strong Buy
NAMS$16.26$44.40+173.06%Buy
AAPG$19.12N/AN/A
View Top Biotech Stocks

Janux Therapeutics Stock Forecast FAQ

Is Janux Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: JANX) stock is to Strong Buy JANX stock.

Out of 6 analysts, 3 (50%) are recommending JANX as a Strong Buy, 2 (33.33%) are recommending JANX as a Buy, 1 (16.67%) are recommending JANX as a Hold, 0 (0%) are recommending JANX as a Sell, and 0 (0%) are recommending JANX as a Strong Sell.

If you're new to stock investing, here's how to buy Janux Therapeutics stock.

What is JANX's earnings growth forecast for 2025-2027?

(NASDAQ: JANX) Janux Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Janux Therapeutics's earnings in 2025 is -$68,994,000.On average, 7 Wall Street analysts forecast JANX's earnings for 2025 to be -$130,959,274, with the lowest JANX earnings forecast at -$196,229,088, and the highest JANX earnings forecast at -$86,884,566. On average, 5 Wall Street analysts forecast JANX's earnings for 2026 to be -$149,772,442, with the lowest JANX earnings forecast at -$286,068,911, and the highest JANX earnings forecast at -$91,612,978.

In 2027, JANX is forecast to generate -$201,548,551 in earnings, with the lowest earnings forecast at -$325,078,309 and the highest earnings forecast at -$104,616,110.

What is JANX's revenue growth forecast for 2027-2029?

(NASDAQ: JANX) Janux Therapeutics's forecast annual revenue growth rate of 240.01% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Janux Therapeutics's revenue in 2025 is $10,588,000.On average, 1 Wall Street analysts forecast JANX's revenue for 2027 to be $1,988,297,145, with the lowest JANX revenue forecast at $1,988,297,145, and the highest JANX revenue forecast at $1,988,297,145. On average, 3 Wall Street analysts forecast JANX's revenue for 2028 to be $8,438,737,363, with the lowest JANX revenue forecast at $6,340,563,750, and the highest JANX revenue forecast at $12,074,590,481.

In 2029, JANX is forecast to generate $25,985,932,509 in revenue, with the lowest revenue forecast at $9,663,100,483 and the highest revenue forecast at $42,931,614,575.

What is JANX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: JANX) forecast ROA is -13%, which is lower than the forecast US Biotechnology industry average of 36.07%.

What is JANX's Price Target?

According to 6 Wall Street analysts that have issued a 1 year JANX price target, the average JANX price target is $97.67, with the highest JANX stock price forecast at $200.00 and the lowest JANX stock price forecast at $41.00.

On average, Wall Street analysts predict that Janux Therapeutics's share price could reach $97.67 by Mar 3, 2026. The average Janux Therapeutics stock price prediction forecasts a potential upside of 233.33% from the current JANX share price of $29.30.

What is JANX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: JANX) Janux Therapeutics's current Earnings Per Share (EPS) is -$1.28. On average, analysts forecast that JANX's EPS will be -$2.22 for 2025, with the lowest EPS forecast at -$3.32, and the highest EPS forecast at -$1.47. On average, analysts forecast that JANX's EPS will be -$2.53 for 2026, with the lowest EPS forecast at -$4.84, and the highest EPS forecast at -$1.55. In 2027, JANX's EPS is forecast to hit -$3.41 (min: -$5.50, max: -$1.77).

What is JANX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: JANX) forecast ROE is -13.49%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.